Breast Cancer Research

Fondazione Michelangelo is involved in clinical research focused on invasive breast cancer, with particular attention to HER2-positive early high-risk and locally advanced disease.

• Neoadjuvant therapy for breast cancer
• HER2-targeted treatment strategies
• Immunotherapy in solid tumours

The sponsor’s active trial network spans multiple collaborating research sites across Europe, supporting investigation in oncology and breast cancer care.